Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00299312 · ClinicalTrials.gov registry record
Genetic and Physical Characteristics of Rett Syndrome
A clinical trial, sponsored by University of Alabama at Birmingham.
- Completed
- Registry status
- 10
- Enrollment target
NCT00299312 is a clinical trial that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 10 participants.
The verdict
NCT00299312 has completed, sponsored by University of Alabama at Birmingham.
- COMPLETED
- Registry status
- 10 participants
- Enrollment target
Study Summary
Rett Syndrome (RTT) is a genetic brain disorder that occurs almost exclusively in females and is usually caused by a change (mutation) in the gene MECP2. The disorder is characterized by multiple developmental problems, as well as behavioral features, such as repetitive stereotypic hand movements, including hand washing, wringing, and tapping. While there is no cure for RTT, recent advances in the understanding of the disease suggest that the development of new, effective therapies is promising. This study will gather information on the genetic defects that cause RTT, the physical expressions of these defects, and disease progression. In turn, this may direct the development of future treatments. Expanded studies include individuals with MECP2 Duplication disorder, and RTT-related disorders including individuals with MECP2 mutations, but not meeting obligatory criteria for the diagnosis of RTT and individuals with mutations in CDKL5 and FOXG1 some of whom meet criteria for atypical RTT.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2006-03 |
| Est. Completion | 2015-10 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00299312
The ClinicalTrials.gov registry entry for NCT00299312 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00299312 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00299312 about?
NCT00299312 is a clinical study titled "Genetic and Physical Characteristics of Rett Syndrome". Rett Syndrome (RTT) is a genetic brain disorder that occurs almost exclusively in females and is usually caused by a change (mutation) in the gene MECP2. The disorder is characterized by multiple developmental problems, as well as behavioral features, such as repetitive stereotypic hand movements, i...
What is the current status of trial NCT00299312?
This trial is currently completed. The enrollment target is 10 participants. The study started on 2006-03. Estimated completion is 2015-10.
Who is sponsoring clinical trial NCT00299312?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.